跳至主要内容
临床试验/JPRN-UMIN000053400
JPRN-UMIN000053400招募中未知

Prospective study of indoleamine 2,3-dioxygenase activity by mesenchymal stem cell in acute GVHD treatment - Prospective study of indoleamine 2,3-dioxygenase activity by mesenchymal stem cell in acute GVHD treatment

Gifu municipal hospital0 个研究点目标入组 52 人开始时间: 2024年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients with a history of previous administration of TEMCELL. (2) Patients who are not scheduled to receive TEMCELL at the dosage and administration according to the attached document. (3) Other patients who are judged to be unsuitable for the indication by the physician's judgment.

研究者

相似试验